ARCHIVES

Zofran Label Change Includes Warnings of QT Prolongation

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

DeVita Considers Laetrile Tests

June 3, 1977

Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million

January 19, 1979

In Brief: CREG To Be Used In Viral Oncology, Nutrition, Cell Kinetics, Immunology, Rauscher Tells NCAB

April 4, 1975

Caterpillar In. Benefits Plan To Cover Entry On BMT trials

June 14, 1996

In Brief: Taxol Development Is NCI ‘Emergency Priority’, Dodd To Focus ACS Effort On Breast Screening

December 7, 1990

UICC Merit Award Winners Announced

September 19, 1986